SCHEMBL7498246

SCHEMBL7498246

Cn1c2cccc(Br)c2c2c(CC#N)nn(-c3ccccc3)c(=O)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
TSPO P30536 1/20 0.41
MAPK1 P28482 1/20 0.37
MAPT P10636 3/20 0.37
TP53 P04637 1/20 0.37
ADORA3 P0DMS8 1/20 0.36
BCAT1 P54687 1/20 0.36
LMNA P02545 1/20 0.35
ALDH1A1 P00352 2/20 0.34
RXFP1 Q9HBX9 1/20 0.34
GAA P10253 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
TSHR P16473 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7497735 0.86 TSPO (0.43) KDM4ETSPOMAPK1MAPTTP53
SCHEMBL7751594 0.83 TSPO (0.50) KDM4ETSPOMAPK1MAPTTP53
SCHEMBL7495976 0.80 CDK1 (0.44) KDM4EMAPK1ADORA3ALDH1A1RXFP1
SCHEMBL7496512 0.80 TSPO (0.47) KDM4ETSPOMAPK1MAPTTP53
SCHEMBL7494763 0.78 TSPO (0.45) KDM4ETSPOMAPK1MAPTTP53
SCHEMBL7492444 0.77 TSPO (0.46) KDM4ECYP1A2CYP2D6CYP2C19TSPO
SCHEMBL5702800 0.77 TSPO (0.68) KDM4ETSPO
SCHEMBL7497324 0.77 TSPO (0.57) KDM4ECYP1A2CYP2D6CYP2C19TSPO
SCHEMBL7499481 0.72 MAOB (0.53) KDM4ECYP1A2CYP2D6CYP2C19TSPO
SCHEMBL24876803 0.72 MAPK13 (0.37) KDM4ECYP1A2CYP2D6CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000063-B1 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY SANOFI SYNTHELABO (FR) 2002-10-23 EP disclosed
US-6262045-B1 TREATMENT OF ANXIETY; SLEEP DISORDER; EPILEPSY; SPASTICITY; MUSCLE CONTRACTURE OR AN EXTRAPYRAMIDAL SYNDROM; INDUCING OR MAINTAINING ANAESTHESIA SANOFI-SYNTHELABO (FR) 2001-07-17 US disclosed